Dual stem-cell transplant improves outlook for children with high-risk neuroblastoma

Posted by on June 6, 2016 2:37 pm
Categories: health

Children with high-risk neuroblastoma whose treatment included two autologous stem-cell transplants were more likely to be free of cancer three years later than patients who underwent a single transplant, a Phase 3 clinical trial has found. The tandem transplant technique produced even better results when followed by treatment with immunotherapy agents.

Leave a Reply

Your email address will not be published. Required fields are marked *